Routine health check-ups may not extend life, new studies reveal
Routine health check-ups may not extend life, new studies reveal
Routine health check-ups may not extend life, new studies reveal
New research has cast doubt on the benefits of routine health check-ups for adults. Studies from Denmark and the U.S. suggest these regular examinations may not extend life expectancy or cut deaths from heart disease. Meanwhile, concerns about overdiagnosis in prostate cancer screenings have also grown.
Danish and American researchers analysed data on general health screenings. Their findings showed no clear link between routine check-ups and longer lifespans. Hospitalisations for cardiovascular issues also remained largely unchanged.
A separate study found that personalised risk assessments and regular blood pressure checks had only a minor effect. These measures slightly lowered hospital admissions but did not significantly improve overall health outcomes.
In another area of concern, prostate cancer screenings have come under scrutiny. By age 80, around 80% of men show signs of the disease, yet very few die from it. Experts warn that widespread testing could lead to unnecessary treatments. Reto Auer, a general practitioner, noted that routine check-ups might be redundant for patients already under medical care for specific conditions.
The research challenges long-held assumptions about the value of regular health screenings. While targeted monitoring—like blood pressure checks—can have small benefits, broader routine exams appear to offer little advantage. The findings also highlight the risks of overdiagnosis in conditions such as prostate cancer.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?